{"id":432198,"title":"Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T07:30:33.123000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/premarket-transparency-initiatives-notice.html","snippet":"Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs August 21, 2018 Our file number: 18-109-632-884 Phase III of Pre-Market Transparency Initiatives for Prescription Drugs As a regulator, Health Canada plays an important role in protecting the health…","rawSnapshotUrl":"/api/snapshots/raw/432198","browseUrl":"https://replay.healtharchive.ca/job-6/20260102073033/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/premarket-transparency-initiatives-notice.html#ha_snapshot=432198","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}